Proposed Data Collection Submitted for Public Comment and Recommendations, 26289-26290 [2018-12082]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 109 / Wednesday, June 6, 2018 / Notices
the health of members of this class.
SDRR was established to aid the
Advisory Board in carrying out its duty
to advise the Secretary, HHS, on dose
reconstruction.
Matters To Be Considered: The agenda
will include discussions on the
following dose reconstruction program
quality management and assurance
activities: Dose reconstruction cases
under review from Sets 19—24,
including Iowa Ordinance Plant,
Nevada Test Site, Los Alamos National
Laboratory, Feeds Material Production
Center (Fernald), Pantex Plant, Rocky
Flats Plant, W.R. Grace, Hanford,
Savannah River Site, Fernald, GE
Evendale, Texas City Chemicals, Canoga
Avenue Facility, De Soto Avenue
Facility, Pacific Northwest National
Laboratory, Amchitka Island Nuclear
Explosion Site, Oak Ridge facilities,
Paducah Gaseous Diffusion Plant, and
potentially other Department of Energy
and Atomic Weapons Employers
facilities.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2018–12149 Filed 6–5–18; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–18–0920; Docket No. CDC–2018–
0053]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
daltland on DSKBBV9HB2PROD with NOTICES
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
SUMMARY:
VerDate Sep<11>2014
17:35 Jun 05, 2018
Jkt 244001
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Data Collection Through Web
Based Surveys for Evaluating Act
Against AIDS Social Marketing
Campaign Phases Targeting Consumers
which includes web surveys to test
campaign messaging.
DATES: CDC must receive written
comments on or before August 6, 2018.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2018–
0053 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Leroy A.
Richardson, Information Collection
Review Office, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, MS–D74, Atlanta, Georgia
30329; phone: 404–639–7570; Email:
omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
26289
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Data Collection Through Web Based
Surveys for Evaluating Act Against
AIDS Social Marketing Campaign
Phases Targeting Consumers—
Extension—National Center for HIV/
AIDS, Viral Hepatitis, STD and TB
Prevention (NCHHSTP, Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
In response to the continued HIV
epidemic in our country, CDC launched
Act Against AIDS (AAA), a multifaceted
communication campaign to reduce HIV
incidence in the United States in 2009.
CDC has released the campaign in
phases, with some of the phases running
concurrently. Each phase of the
campaign uses mass media and directto-consumer channels to deliver
messages. Some campaigns provide
basic education and increase awareness
of HIV/AIDS among the general public
whereas others emphasize HIV
prevention and testing among specific
subgroups or communities at greatest
risk of infection. CDC will also develop
new messages to address changes in
prevention science and subpopulations
affected by HIV. The proposed study
will assess the effectiveness of these
social marketing messages aimed at
increasing HIV/AIDS awareness,
increasing prevention behaviors, and
improving HIV testing rates among
consumers.
This extension of an ongoing study
will allow for continued evaluation of
the effectiveness of AAA social
marketing campaign through surveys
with consumers. A total of 10,750
respondents were approved for the
previously renewed generic ICR (0920–
0920) and since the approval date, 4,305
respondents were surveyed under the
GenIC, ‘‘Development of Messages for
E:\FR\FM\06JNN1.SGM
06JNN1
26290
Federal Register / Vol. 83, No. 109 / Wednesday, June 6, 2018 / Notices
the Act Against AIDS National Testing’’.
The information collected from these
data collections was used to evaluate a
specific AAA campaign phase. We are
requesting the same amount of time to
continue surveying AAA target
audiences as new phases are developed.
Through this extension, we plan to
reach the remaining approved 6,445
respondents. To obtain the remaining
respondents, we anticipate screening
approximately 32,220 individuals.
Depending on the target audience for
the campaign phase, the study screener
will vary. The study screener may
address one or more of the following
items: Race/ethnicity, sexual behavior,
sexual orientation, gender identity, HIV
testing history, HIV status, and injection
drug use. Each survey will have a core
set of items asked in all rounds, as well
as a module of questions relating to
specific AAA phases and activities.
Respondents will be recruited through
national opt-in email lists, the internet,
and external partnerships with
community-based and membership
organizations that work with or
represent individuals from targeted
populations (e.g., National Urban
League, the National Medical
Association). Respondents will selfadminister the survey at home on
personal computers. There is no cost to
the respondents other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Average
burden per
response
(in hours)
Total
burden
(in hours)
Type of respondents
Form name
Individuals (male and female) aged 18 years and
older.
Study Screener .............
Survey ..........................
10,740
2,148
1
1
2/60
30/60
358
1,074
Total ...............................................................
.......................................
........................
........................
........................
1,432
Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
section of this notice that your
comments address.
1.0 Background
Administration for Children
and Families (ACF), U.S. Department of
Health and Human Services (HHS).
ACTION: Request for public comment.
1.1 Legislative Context
The Consolidated Appropriations Act
of 2017 (Pub. L. 115–31 (https://
www.congress.gov/115/plaws/publ31/
PLAW-115publ31.pdf)) directs the U.S.
Department of Health and Human
Services (HHS) to create a database of
projects that have used a proven or
promising approach to move welfare
recipients into work, based on
independent, rigorous evaluations of the
projects, and to create a What Works
Clearinghouse of Proven and Promising
Projects to Move Welfare Recipients into
Work. As stated in the statute, the
database shall additionally ‘‘include a
separate listing of projects that used a
developmental approach in delivering
services and a further separate listing of
the projects with no or negative effects.’’
The statute requires HHS to establish
criteria for evidence of effectiveness.
The Administration for
Children and Families, HHS, solicits
comments by August 5, 2018 on the
criteria for evidence of effectiveness for
the What Works Clearinghouse of
Proven and Promising Projects to Move
Welfare Recipients into Work. Final
criteria for evidence of effectiveness will
be used to develop the clearinghouse.
SUPPLEMENTARY INFORMATION:
Invitation to Comment: HHS invites
comments regarding this notice on the
proposed criteria for HHS’s systematic
review of the evidence. To ensure that
your comments are clearly stated, please
identify the specific criterion or other
1.2 The Legislation’s Direction for
Establishing the Criteria for Evidence of
Effectiveness
Section 413(g)(2) of Public Law 115–
31 charges the Secretary of Health and
Human Services with establishing the
criteria of effectiveness. The statute
further stipulated that the (B) process
for establishing the criteria—
(i) is transparent;
(ii) is consistent across agencies;
(iii) provides opportunity for public
comment; and
(iv) takes into account efforts of
Federal agencies to identify and
publicize effective interventions,
including efforts at the Department of
[FR Doc. 2018–12082 Filed 6–5–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Criteria for Evidence of Effectiveness
To Be Applied to Projects Identified for
Inclusion in the What Works
Clearinghouse of Proven and
Promising Projects To Move Welfare
Recipients Into Work
AGENCY:
daltland on DSKBBV9HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:35 Jun 05, 2018
Jkt 244001
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Health and Human Services, the
Department of Education, and the
Department of Justice.
1.3 The Employment Strategies for LowIncome Adults Evidence Review
Prior to the enactment of Public Law
115–31, the Office of Planning,
Research, and Evaluation (OPRE) at the
Administration for Children and
Families (ACF) at HHS had developed
the Employment Strategies for LowIncome Adults Evidence Review (ESER).
The new statute aligns with and extends
the work of ESER. HHS proposes
building on this existing work to
develop the new Clearinghouse.
The Employment Strategies for LowIncome Adults Evidence Review (ESER)
is a systematic review of the evaluation
research published between 1990 and
2014 on employment and training
programs for low-income adults. It
culminated in a searchable, public
database (https://
employmentstrategies.acf.hhs.gov/). The
review was supplemented with briefs
synthesizing the results of the review
and highlighting strategies that
appeared to be promising, as identified
by the review. To identify the programs
and strategies—or interventions— that
appear to be most effective in helping
low-income adults gain and retain
employment, ESER systematically
identified, assessed, and synthesized
evidence from the existing evaluation
research literature. A core component of
ESER’s review, as with other federal
evidence reviews, involved assessing
the quality of the research evidence on
different interventions.
To assess the quality of the evidence,
ESER reviewed each study’s methods to
E:\FR\FM\06JNN1.SGM
06JNN1
]]>Agencies
[Federal Register Volume 83, Number 109 (Wednesday, June 6, 2018)]
[Notices]
[Pages 26289-26290]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-12082]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-18-0920; Docket No. CDC-2018-0053]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Data Collection Through Web Based
Surveys for Evaluating Act Against AIDS Social Marketing Campaign
Phases Targeting Consumers which includes web surveys to test campaign
messaging.
DATES: CDC must receive written comments on or before August 6, 2018.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2018-
0053 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Leroy A. Richardson, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Data Collection Through Web Based Surveys for Evaluating Act
Against AIDS Social Marketing Campaign Phases Targeting Consumers--
Extension--National Center for HIV/AIDS, Viral Hepatitis, STD and TB
Prevention (NCHHSTP, Centers for Disease Control and Prevention (CDC).
Background and Brief Description
In response to the continued HIV epidemic in our country, CDC
launched Act Against AIDS (AAA), a multifaceted communication campaign
to reduce HIV incidence in the United States in 2009. CDC has released
the campaign in phases, with some of the phases running concurrently.
Each phase of the campaign uses mass media and direct-to-consumer
channels to deliver messages. Some campaigns provide basic education
and increase awareness of HIV/AIDS among the general public whereas
others emphasize HIV prevention and testing among specific subgroups or
communities at greatest risk of infection. CDC will also develop new
messages to address changes in prevention science and subpopulations
affected by HIV. The proposed study will assess the effectiveness of
these social marketing messages aimed at increasing HIV/AIDS awareness,
increasing prevention behaviors, and improving HIV testing rates among
consumers.
This extension of an ongoing study will allow for continued
evaluation of the effectiveness of AAA social marketing campaign
through surveys with consumers. A total of 10,750 respondents were
approved for the previously renewed generic ICR (0920-0920) and since
the approval date, 4,305 respondents were surveyed under the GenIC,
``Development of Messages for
[[Page 26290]]
the Act Against AIDS National Testing''. The information collected from
these data collections was used to evaluate a specific AAA campaign
phase. We are requesting the same amount of time to continue surveying
AAA target audiences as new phases are developed.
Through this extension, we plan to reach the remaining approved
6,445 respondents. To obtain the remaining respondents, we anticipate
screening approximately 32,220 individuals. Depending on the target
audience for the campaign phase, the study screener will vary. The
study screener may address one or more of the following items: Race/
ethnicity, sexual behavior, sexual orientation, gender identity, HIV
testing history, HIV status, and injection drug use. Each survey will
have a core set of items asked in all rounds, as well as a module of
questions relating to specific AAA phases and activities.
Respondents will be recruited through national opt-in email lists,
the internet, and external partnerships with community-based and
membership organizations that work with or represent individuals from
targeted populations (e.g., National Urban League, the National Medical
Association). Respondents will self-administer the survey at home on
personal computers. There is no cost to the respondents other than
their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Individuals (male and female) Study Screener.. 10,740 1 2/60 358
aged 18 years and older. Survey.......... 2,148 1 30/60 1,074
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 1,432
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Acting Chief, Information Collection Review Office, Office of
Scientific Integrity, Office of the Associate Director for Science,
Office of the Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-12082 Filed 6-5-18; 8:45 am]
BILLING CODE 4163-18-P
